Scientist in Microbial Upstream Process Development

Scientist within Microbial upstream process development
Sobi is an international pharmaceutical company focusing on finding new orphan drugs. Sobi’s main therapeutic areas are inflammation, hemophilia and genetically diseases. Sobi R&D’s mission is to develop and deliver innovative therapies that improve the lives of patients and their families.

At Sobi you make a difference!

The department Biopharmaceuticals R&D is growing and looking for new scientists. The main focus for the department is development of drug substance and drug product. It also supports projects through the value chain from preclinical to product support and Life Cycle Management.

Expression and Upstream Development is a section within Biopharmaceuticals R&D responsible for development of stable expression systems and robust cultivation processes for scale-up purposes. The section work with both mammalian and microbial cells. The team is highly experienced and the environment is very collaborative.

Sobi is offering a laborative position in a development oriented organization where everyone is engaged in making a better life of patients suffering from rare disease. If you share that engagement and enjoys the lab work you will prosper with us.

Your work tasks will be:

• Develop, optimize and scale-up microbial upstream processes in reactor scale to progress projects from early to late development.
• Lead project sub-teams within your field as required.
• Develop project plans and strategies with project and line
• Communicate between project, project sub-team, and line management
• Write, review, and approve technical reports and documentation for regulatory submissions
• Support scale-up of processes to GMP site (internal/external)
• Development and maintenance of expertise within microbial process development.
• Practical experience of expression systems is a merit.


Qualifications:

• At least M.Sc in Biotechnology or related area with significant relevant experience in an R&D environment. Lic. or Ph.D. is a merit.
• 2 years of relevant industrial experience
• Practical and theoretical knowledge of development, optimization and scale-up of microbial processes.
• Able to write publishable technical reports. Experience of writing regulatory submissions is a merit.
• Fluent in both oral and written English. Swedish fluency is a merit.
• Knowledge of midstream technologies is a merit
• Practical experience of mammalian process development in reactor scale and/or molecular biology are merits.


To be successful as a scientist at Sobi you need to be open, flexible, and a team player with proven communication skills and interest in other colleagues' perspectives and development. You are result-oriented, structured and have leadership skills.

You are willing to work outside usual office hours (week-ends, early morning or late night) as agreed with line manager.

If you share our core values: Collaborative, Accountable, Respectful and Engaged, you will enjoy working with us.

Business: Sobi

City: Solna

Employment: full time, open ended

Last date of application: 2016-05-08

For information: In this recruitment Sobi is collaborating with Dfind Science & Engineering. For questions please contact responsible recruitment consultant Rebecca Dovega 072-547 99 19. Apply via www.dfind.se/science-engineering [ file://404000files.ad.proffice.com/dokument.ny/Dfind Science & Engineering/Kunder/SOBI/SOBI 2016/Scientist Bioassay/www.dfind.se/science-engineering ] no later than 2016-05-08

Organization and Business description:

Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primary focused on Haemophilia, Inflammation and Genetic diseases. We also market a portfolio of speciality and rare disease products for partner companies across Europe, the Middle East, North Africa and Russia. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2015, Sobi had total revenues of SEK 3.2 billion (USD 385 M) and approximately 700 employees. The share (STO:SOBI) is listed on NASDAQ OMX Stockholm. More information is available at www.sobi.com [ http://www.sobi.com/ ]